Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Comparison between different batches and global analysis

    Hello everyone,

    I have RNA-seq data coming from control, breast cancer and endometrial cancer patients. Is an ongoing study and so far we've sequenced 15 patients (5 control, 5 breast cancer and 5 endometrial cancer) about a year ago and 5 patients (1 control, 2 breast cancer and 2 endometrial cancer) a month ago.

    I want to compare between the independent batches and also combine them and do a global analysis. I did an independent DE analysis on each batch using EdgeR and DESeq2 however when i compare the gene lists I have very few common DE genes. Do I need to do some kind of normalisation before i compare them? About the global analysis, I will put everything together but how can I correct for batch effects?

    Thank you so much!

  • #2
    Just a general comment first.
    I've have very poor results regarding correlation between human clinical samples.
    There are too many variables that are not controlled for.
    Often, when you enquire about the collection method of the samples, you'll find that they are not identical for all samples, e.g. some samples were frozen for a long period of time, the tumor samples contain different proportions of normal tissue, ...
    I've often been unpleasantly surprised that the samples that were described to me as replicates actually had significant differences.
    The best results are generally obtained when the person collecting the samples is experienced in RNA-Seq analysis, and is aware how the collection and preparation of the samples can affect the downstream analysis.

    There are also variations between cancers, but that is biologically relevant.

    As an analyst, you need to get as much information as possible about the collection method of the samples, and collect as much metrics as possible to better understand the samples (e.g. RNA integrity number for all the samples, exotic alignment rate, ...).

    -----

    Second, you have few or no replicates in your second batch so you would expect DESeq and edgeR to give you a different list of differentially expressed genes. In the second batch for example, you have no control replicates which will affect the calculation of the dispersion level by DESeq and edgeR.

    -----

    To answer your question though, I would first try clustering the samples using the normalized counts. If the samples do no cluster according to the tissue of origin but rather according to the batch, I would try removing the batch effect with ComBat. I would then repeat the clustering to verify if ComBat has successfully removed the batch effect.
    Last edited by blancha; 05-18-2014, 10:01 AM.

    Comment


    • #3
      Thank you very much for you answer blancha.
      I'll try using comBat!

      Comment

      Latest Articles

      Collapse

      • seqadmin
        Essential Discoveries and Tools in Epitranscriptomics
        by seqadmin




        The field of epigenetics has traditionally concentrated more on DNA and how changes like methylation and phosphorylation of histones impact gene expression and regulation. However, our increased understanding of RNA modifications and their importance in cellular processes has led to a rise in epitranscriptomics research. “Epitranscriptomics brings together the concepts of epigenetics and gene expression,” explained Adrien Leger, PhD, Principal Research Scientist...
        04-22-2024, 07:01 AM
      • seqadmin
        Current Approaches to Protein Sequencing
        by seqadmin


        Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
        04-04-2024, 04:25 PM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by seqadmin, Yesterday, 11:49 AM
      0 responses
      15 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 04-24-2024, 08:47 AM
      0 responses
      16 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 04-11-2024, 12:08 PM
      0 responses
      61 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 04-10-2024, 10:19 PM
      0 responses
      60 views
      0 likes
      Last Post seqadmin  
      Working...
      X